Brackenridge, A L, Jackson, N, Jefferson, W, Stolinski, M, Shojaee-Moradie, F, Hovorka, R, Umpleby, A M and Russell-Jones, D (2009) Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids. Diabetic Medicine, 26(5), pp. 532-539. ISSN (print) 0742-3071
Official URL: http://dx.doi.org/10.1111/j.1464-5491.2009.02729.x
Abstract
In patients with Type 2 diabetes and normal lipids, treatment with rosiglitazone or pioglitazone had no significant effect on lipoprotein metabolism compared with placebo.
Actions (Repository Editors)
 |
Item Control Page |